Related Experiment Video
Updated: Mar 22, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Pediatric weight management interventions in primary care settings: A meta-analysis
Summary
Pediatric weight management interventions in primary care settings show a small but significant reduction in body mass index (BMI). Longer, more frequent treatment contacts, especially with pediatricians, enhance effectiveness for childhood obesity treatment.
Area of Science:
- Pediatric Health
- Obesity Research
- Evidence-Based Practice
Background:
- Primary care is recommended for pediatric overweight/obesity treatment.
- Quantitative evidence on intervention effectiveness in primary care is lacking.
Purpose of the Study:
- To conduct a meta-analysis on pediatric weight management interventions in primary care settings.
- To determine the effectiveness of these interventions for youth.
Main Methods:
- A systematic literature search of PsycINFO and PubMed was performed.
- Eighteen studies with 3,358 participants were included.
- Study characteristics and rigor were assessed.
Main Results:
- Interventions showed a small, statistically significant reduction in body mass index (BMI) (d = 0.26).
- Treatment duration, number of contacts, and pediatrician involvement moderated outcomes.
- Greater contact frequency positively correlated with BMI reduction.
Conclusions:
- Weight management programs in primary care are effective for reducing pediatric BMI.
- Primary care is a suitable setting for treating childhood overweight/obesity.
- Intervention intensity and pediatrician contact are key factors for success.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
317
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
317
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
441
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
01:29Drug Dosing: Infants and Children
713
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
713
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
368
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
01:21Drug Dosing: Obese Patients
334
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
669
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669